申请人:Rhone-Poulenc Sante
公开号:US05159114A1
公开(公告)日:1992-10-27
Benzanilide derivatives of the formula: ##STR1## wherein R.sup.1 is alkyl optionally containing double or triple bonds, and optionally interrupted by one or more hetero atoms; R.sup.2 is hydrogen, methyl, or ethyl; R.sup.3 is halogen, alkyl, --OY, --SY, or dimethylamino; R.sup.4 and R.sup.5 are hydrogen, alkyl optionally containing double or triple bonds, or --(CH.sub.2).sub.m --Z, wherein: Z is --OCH.sub.3, --SCH.sub.3, --N(CH.sub.3).sub.2 or alkanoylamino, and m is 2, 3 or 4; X is oxygen, --OCH.sub.2 --, --S--, --SCH.sub.2 -- or --NR.sup.6 --; R.sup.6 is hydrogen, methyl, ethyl, or acyl; and Y is alkyl; are useful as anti-atherosclerotic agents.
式为:##STR1##的苯基酰胺衍生物,其中R.sup.1是含有双键或三键的烷基,且可以被一个或多个杂原子中断;R.sup.2是氢、甲基或乙基;R.sup.3是卤素、烷基、--OY、--SY或二甲基氨基;R.sup.4和R.sup.5是氢、含有双键或三键的烷基,或--(CH.sub.2).sub.m --Z,其中:Z是--OCH.sub.3、--SCH.sub.3、--N(CH.sub.3).sub.2或烷酰胺基,而m是2、3或4;X是氧、--OCH.sub.2 --、--S--、--SCH.sub.2 --或--NR.sup.6 --;R.sup.6是氢、甲基、乙基或酰基;而Y是烷基。这些化合物可用作抗动脉粥样硬化剂。